Sage Journals: Discover world-class research

Abstract

Background

Analgesics, sedatives, and antipsychotics are commonly prescribed for agitation and delirium in the intensive care unit (ICU), but their use is limited by adverse effects and lack of efficacy. Valproic acid is an alternative treatment option.

Objective

The primary objective of this study was to describe valproic acid prescribing in our institution’s ICUs when used for agitation or delirium. Measures of effectiveness and safety were also assessed.

Methods

This was a single-center, retrospective, institutional review board–approved cohort study of adult inpatients admitted to the ICU between January 2018 and August 2018. Patients who received valproic acid for the treatment of agitation or delirium for ≥24 hours were included. Prescribing practices were evaluated for dose, frequency, and route of administration. Effectiveness was assessed via agitation and delirium assessment tools and quantity of adjunctive agents used.

Results

A total of 80 patients were included, with 35 receiving valproic acid alone and 45 in conjunction with antipsychotics. The most common valproic acid regimen was 250 mg orally 3 times daily. Delirium resolution occurred in 55% of patients: 24 in the valproic acid monotherapy group and 20 in the valproic acid plus antipsychotic group (69% vs 44%; P = 0.03). The incidence of delirium decreased from valproic acid day 0 to day 3 (93% vs 68%; P < 0.01), with no change in agitation (64% vs 63%; P = 0.28).

Conclusion and Relevance

Valproic acid is frequently prescribed in agitated, delirious patients at our institution and may have a role in the management of ICU delirium.

Keywords

valproic acid agitation delirium critical illness sedation

Get full access to this article

View all access options for this article.

References

Salluh

Soares

Teles

, et al. Delirium epidemiology in critical care (DECCA): an international study. Crit Care. 2010;14:R210.

Ely

Margolin

Francis

, et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001;29:1370-1379.

Ely

Inouye

Bernard

, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286:2703-2710.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013.

Meagher

Trzepacz

PT.

Motoric subtypes of delirium. Semin Clin Neuropsychiatry. 2000;5:75-85.

Peterson

Pun

Dittus

, et al. Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc. 2006;54:479-484.

Pun

Ely

EW.

The importance of diagnosing and managing ICU delirium. Chest. 2007;132:624-636.

Milbrandt

Deppen

Harrison

, et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med. 2004;32:955-962.

Ely

Gautam

Margolin

, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001;27:1892-1900.

10.

Ely

Shintani

Truman

, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291:1753-1762.

11.

Girard

Jackson

Pandharipande

, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38:1513-1520.

12.

Patel

Gambrell

Speroff

, et al. Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med. 2009;37:825-832.

13.

Ely

Stephens

Jackson

, et al. Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals. Crit Care Med. 2004;32:106-112.

14.

DAS-Taskforce 2015; Baron

Binder

, et al. Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine: revision 2015 (DAS-Guideline 2015)—short version. Ger Med Sci. 2015;13:Doc19.

15.

Tropea

Slee

Brand

Gray

Snell

Clinical practice guidelines for the management of delirium in older people in Australia. Australas J Ageing. 2008;27:150-156.

16.

Devlin

Skrobik

Gélinas

, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46:e825-e873.

17.

Devlin

Roberts

Fong

, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med. 2010;38:419-427.

18.

Lonergan

Britton

Luxenberg

Wyller

Antipsychotics for delirium. Cochrane Database Syst Rev. 2007;(2):CD005594.

19.

Glassman

Bigger

Jr.

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001;158:1774-1782.

20.

Gagnon

Fontaine

Riker

Fraser

GL.

Repurposing valproate, enteral clonidine, and phenobarbital for comfort in adult ICU patients: a literature review with practical considerations. Pharmacotherapy. 2017;37:1309-1321.

21.

Depakene. Package insert. AbbVie Inc; 2020.

22.

Bourgeois

Koike

Simmons

Telled

Eggleston

Adjunctive valproic acid for delirium and/or agitation on a consultation-liaison service: a report of six cases. J Neuropsychiatry Clin Neurosci. 2005;17:232-238.

23.

Sher

Miller

Lolak

Ament

Maldonado

JR.

Adjunctive valproic acid in management-refractory hyperactive delirium: a case series and rationale. J Neuropsychiatry Clin Neurosci. 2015;27:365-370.

24.

Gagnon

Fontaine

Smith

, et al. Valproate for agitation in critically ill patients: a retrospective study. Crit Care. 2017;37:119-125.

25.

Fitz

Harding

851: Safety and efficacy of valproic acid for treatment of delirium in critically ill patients. Crit Care Med. 2011;39:239.

26.

Crowley

Urben

Hacobian

Geiger

KL.

Valproic acid for the management of agitation and delirium in the intensive care setting: a retrospective analysis. Clin Ther. 2020;42:e65-e73. doi:10.1016/j.clinthera.2020.02.007

27.

Harris

Taylor

Thielke

Payne

Gonzalez

Conde

JG.

Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381.

28.

Brunton

Chabner

Knollmann

BC.

Pharmacotherapy of the epilepsies, valproic acid. In: Brunton

Hilal-Dandan

Knollmann

eds. Goodman & Gilman’s the Pharmacological Basis of Therapeutics. 12th ed. McGraw-Hill; 2011:chap 21.

29.

Depakote. Package insert. AbbVie Inc; 2019.

30.

Hiemke

Bergemann

Clement

, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51: 9-62.

31.

Gauer

Braun

MM.

Thrombocytopenia. Am Fam Physician. 2012;85:612-622.

32.

Jaeschke

Gores

Cederbaum

Hinson

Pessayre

Lemasters

JJ.

Mechanisms of hepatotoxicity. Toxicol Sci. 2002;65:166-176.

33.

Björnsson

ES.

Hepatotoxicity by drugs: the most common implicated agents. Int J Mol Sci. 2016;17:224.

34.

Chicharro

de Marinis

Kanner

AM.

The measurement of ammonia blood levels in patients taking valproic acid: looking for problems where they do not exist?

Epilepsy Behav. 2007;11:361-366.

35.

Baddour

Tewksbury

Stauner

Valproic acid-induced hyperammonemia: incidence, clinical significance, and treatment management. Ment Health Clin. 2018;8:73-77.

36.

Chopra

Kolla

Mansukhani

Netzel

Frye

MA.

Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management. Gen Hosp Psychiatry. 2012;34:290-298.

37.

Marshall

Herzig

Howell

, et al. Antipsychotic utilization in the intensive care unit and in transitions of care. J Crit Care. 2016;33:119-124.

38.

Kram

Brooks

KR.

Implications of atypical antipsychotic prescribing in the intensive care unit. J Crit Care. 2015;30:814-818.

39.

Jasiak

Middleton

Camamo

Erstad

Snyder

Huckleberry

YC.

Evaluation of discontinuation of atypical antipsychotics prescribed for ICU delirium. J Pharm Pract. 2013;26:253-256.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.09 MB